[1] New trends in patient management: risk-based therapy for febrile patients with neutropenia

[2] Infection in cancer patients. A continuing association

[3] Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey

[4] Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults

[5] The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients

[6] Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides

[7] Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome

[8] Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement?